Literature DB >> 6304516

Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children.

R F Bishop, G L Barnes, E Cipriani, J S Lund.   

Abstract

To determine whether rotavirus infection in newborn babies conferred immunity to postneonatal rotavirus infection, we studied 81 babies at birth and kept them under clinical and serologic study for three years. During the first 14 days of life, 44 of the infants excreted rotavirus, and 37 did not. Fifty-five per cent of those with neonatal infection and 54 per cent of those without it had rotavirus infection during the next three years. Symptoms associated with postneonatal rotavirus infection were significantly less frequent and less severe in the infants who had had neonatal infection (P = 0.003) than in those who had not. Thirty-eight per cent of the former group (9 of 24 infants) had symptoms of mild (3 infants) or moderate (6) severity during the first postneonatal infection. In contrast, 85 per cent of the latter group (17 of 20 infants) had mild (3), moderate (6), or severe (8) symptoms. We conclude that neonatal rotavirus infection does not confer immunity against reinfection but does protect against the development of clinically severe disease during reinfection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304516     DOI: 10.1056/NEJM198307143090203

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  105 in total

1.  Detection and characterization of rotaviruses in hospitalized neonates in Blantyre, Malawi.

Authors:  N A Cunliffe; S Rogerson; W Dove; B D M Thindwa; J Greensill; C D Kirkwood; R L Broadhead; C A Hart
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 2.  Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries.

Authors:  Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

3.  Molecular epidemiology of rotavirus in black infants in South Africa.

Authors:  A D Steele; J J Alexander
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

4.  Serum IgG mediates mucosal immunity against rotavirus infection.

Authors:  Larry E Westerman; Harold M McClure; Baoming Jiang; Jeffrey W Almond; Roger I Glass
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-09       Impact factor: 11.205

5.  An age-structured epidemic model of rotavirus with vaccination.

Authors:  E Shim; Z Feng; M Martcheva; C Castillo-Chavez
Journal:  J Math Biol       Date:  2006-08-17       Impact factor: 2.259

6.  Prospective study of community-acquired rotavirus infection.

Authors:  B J Zheng; S K Lo; J S Tam; M Lo; C Y Yeung; M H Ng
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

7.  Studies on attenuation of rotavirus. A comparison in piglets between virulent virus and its attenuated derivative.

Authors:  S Tzipori; L Unicomb; R Bishop; J Montenaro; L M Vaelioja
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

8.  Expression of rotavirus capsid protein VP6 in transgenic potato and its oral immunogenicity in mice.

Authors:  Jie Yu; William Langridge
Journal:  Transgenic Res       Date:  2003-04       Impact factor: 2.788

9.  Determinants of Short-term Movement in a Developing Region and Implications for Disease Transmission.

Authors:  Alicia N M Kraay; James Trostle; Andrew F Brouwer; William Cevallos; Joseph N S Eisenberg
Journal:  Epidemiology       Date:  2018-01       Impact factor: 4.822

Review 10.  Rotavirus vaccines: an overview.

Authors:  Penelope H Dennehy
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.